4.4 Review

Chemically-modified HA for therapy and regenerative medicine

期刊

CURRENT PHARMACEUTICAL BIOTECHNOLOGY
卷 9, 期 4, 页码 242-245

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920108785161523

关键词

cross-linking; gels; scaffolds; biomaterials

资金

  1. NIH
  2. NSF
  3. Center for Biotechnology at the University at Stony Brook
  4. MedChem Products, Inc.
  5. Anika Therapeutics, Inc.
  6. Clear Solutions Biotech, Inc.
  7. Sentrx Surgical, Inc.
  8. University of Utah
  9. Utah Centers of Excellence Program

向作者/读者索取更多资源

Hyaluronan (HA) is a very useful polymer, but its properties sometimes need to be altered or enhanced by chemical modification for biomedical applications. A wide variety of HA derivatives are currently used for eye surgery, joint viscoelastic supplementation, and anti-adhesion films. The future promises to deliver new classes of HA-based reagents as well as new polymers that can be used in situ with living cells or within the body.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据